Day: August 22, 2024

SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024

SANTA CLARA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Morgan Stanley 22nd Annual Global Healthcare Conference in New York. Management will be hosting a fireside chat on Wednesday, September 4, 2024, at 10:45 a.m. Eastern Time / 7:45 a.m. Pacific Time. Investors interested in listening to the conference call may do so by registering at this link: https://url.us.m.mimecastprotect.com/s/r-x6CjRnDNsnPR3wF7sxumTszz?domain=cc.webcasts.com. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event. About SI-BONE, Inc. SI-BONE...

Continue reading

Abercrombie & Fitch Co. Announces Election of Andrew Clarke to its Board of Directors

Clarke brings global, executive leadership and a deep connection to consumers around the world NEW ALBANY, Ohio, Aug. 22, 2024 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF), a leading, global omnichannel specialty retailer of apparel and accessories, today announced the election of Andrew Clarke to its Board of Directors, effective August 21, 2024. Mr. Clarke, 51, is the Global President of Mars Snacking, a division of Mars, Incorporated. In this role, which he has held since 2018, Clarke is responsible for overseeing one of the world’s most iconic portfolio of snack brands, which represents a significant portion of Mars’ total business. He has more than 30 years in consumer-focused industries, with the last 24 years at Mars in roles of increasing responsibility. Clarke started with Mars in UK sales, before moving...

Continue reading

Kane Biotech to Release Second Quarter 2024 Financial Results on August 29, 2024 – Conference Call to Follow

WINNIPEG, Manitoba, Aug. 22, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”) will announce its second quarter 2024 financial results after market close on Thursday, August 29, 2024. Kane Biotech management will host a conference call at 4:30 p.m. ET on August 29, 2024 to review the financial results and discuss business developments in the period. Participants must register for the call using this link: It is recommended that you join 10 minutes before the event, though you may pre-register at any time. A webcast of the call will be available on Kane Biotech’s website at www.kanebiotech.com in the Investor section at ir.kanebiotech.com. About Kane Biotech Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent...

Continue reading

Eton Pharmaceuticals to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

DEER PARK, Ill., Aug. 22, 2024 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced today that the Company will participate at the H.C. Wainwright 26th Annual Global Investment Conference in New York City. The Company’s presentation by Sean Brynjelsen, Chief Executive Officer, will be available on demand commencing on September 9, 2024, at 7am ET. Investors can access the presentation here. To schedule an in-person 1×1 meeting with the Company, please contact Corporate Access at H.C. Wainwright. About Eton Pharmaceuticals Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has five commercial...

Continue reading

Range Announces Retirement of Steve Gray from the Board of Directors

FORT WORTH, Texas, Aug. 22, 2024 (GLOBE NEWSWIRE) — RANGE RESOURCES CORPORATION (NYSE: RRC) today announced that Steve Gray will retire from his position on Range’s Board of Directors, effective October 1, 2024. Range Chairman, Greg Maxwell stated, “We want to express our gratitude to Steve for his dedicated service to Range. Since joining our Board in 2018, Steve has shared his wisdom, industry experience and expertise, helping Range to become a more resilient and efficient Marcellus operator capable of generating free cash flow and returns of capital through price cycles. We wish Steve and his family the best in his retirement.” Steve Gray commented, “During my time on the Range Board, I have seen the Company navigate through tough times, volatile commodity prices, and a pandemic, yet emerge as a stronger company. I am proud...

Continue reading

Travere Therapeutics to Present Abstracts at the Society for the Study of Inborn Errors of Metabolism Annual Symposium 2024

Posters to be presented highlight clinical study designs investigating pegtibatinase as the first potential disease-modifying treatment for classical homocystinuria SAN DIEGO, Aug. 22, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc., (Nasdaq: TVTX) today announced that the Company will present two posters in classical homocystinuria (HCU) at the Society for the Study of Inborn Errors of Metabolism (SSIEM) annual symposium in Porto, Portugal, September 3-6, 2024. At SSIEM, the Company will present the trial designs of the pivotal Phase 3 HARMONY Study and ENSEMBLE long-term extension study of pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of classical HCU. Additionally, the Company will share the trial design of cohort 7 in the Phase 1/2 COMPOSE Study of pegtibatinase in pediatric participants...

Continue reading

Dillard’s, Inc. Announces $0.25 Cash Dividend

LITTLE ROCK, Ark., Aug. 22, 2024 (GLOBE NEWSWIRE) — Dillard’s, Inc. (DDS-NYSE) (the “Company” or “Dillard’s”) announced that the Board of Directors declared a cash dividend of $0.25 per share on the Class A and Class B Common Stock of the Company. The dividend is payable November 4, 2024 to shareholders of record as of September 30, 2024. CONTACT:Julie J. Guymon, C.P.A. 501-376-5965julie.guymon@dillards.com

Continue reading

CORRECTION — InnovAge PACE Celebrates Anniversary of Vibrant Sacramento Center

PACE Program Provides Highly Coordinated Personalized Senior Care in Partnership with Eskaton and Adventist Health In a release issued under the same headline on Friday, August 16, 2024, by InnovAge, please note the staff count four years ago has been corrected from seven to 20 people. The revised release is as follows: SACRAMENTO, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) — InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), celebrated the fourth anniversary of its Sacramento, California center with community members, local representatives, businesses, healthcare providers, and other valued partners. “The demand for affordable, reliable healthcare for seniors is...

Continue reading

Toll Brothers Now Selling Move-In-Ready Homes at its Highlands at Vinings Community in Atlanta, Georgia

ATLANTA, Aug. 22, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, is now offering a limited number of quick move-in and move-in ready homes at Highlands at Vinings, a luxury new home community featuring four-story townhomes with private elevators in each residence and sought-after rooftop terraces in Atlanta, Georgia. The community is located at 2741 Wynberry Lane in the vibrant downtown Vinings area of Atlanta. Brand new, move-in ready townhomes in the community are now available starting at $925,000. Highlands at Vinings is a gated community of just 31 luxury townhomes currently offering home designs with up to 3,553 square feet of living space with 3 bedrooms, 4.5 baths, and 2-car garages. The home designs combine sophisticated living with modern architecture and quality...

Continue reading

BC’s Rental Protection Fund Announces Acquisition of 75 Affordable Rental Units in North Vancouver and Squamish

The acquisition will protect two buildings, securing affordable housing for Indigenous people, seniors and families in rapidly growing communities NORTH VANCOUVER, British Columbia, Aug. 22, 2024 (GLOBE NEWSWIRE) — Today, the Rental Protection Fund (the Fund) announces the acquisition of two rental buildings; a 35-unit building in North Vancouver acquired by Hiy̓ám̓ ta Sḵwx̱wú7mesh Housing Society (Hiy̓ám̓ Housing) and a 40-unit building in Squamish acquired through a partnership between Hiy̓ám̓ Housing and the Squamish Community Housing Society (Housing Squamish). Both acquisitions will safeguard affordable housing for seniors, families, and Indigenous people in communities where rental housing is in short supply. With capital contributions from the Rental Protection Fund, and a $500,000 investment from the Squamish Nation, Hiy̓ám̓...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.